Skip to main content
VivoSim Labs, INC. logo

VivoSim Labs, INC. — Investor Relations & Filings

Ticker · VIVS ISIN · US68620A2033 US Professional, scientific and technical activities
Open in API
Filings indexed 790 across all filing types
Latest filing 2020-08-19 Director's Dealing
Country US United States of America
Listing US VIVS

About VivoSim Labs, INC.

https://organovo.com/

VivoSim Labs, Inc. is a biotechnology services company that develops and utilizes bioprinted, three-dimensional (3D) human tissues designed to emulate human biology and disease. The company provides testing services for drugs and drug candidates, primarily for the pharmaceutical and biotechnology sectors. VivoSim Labs specializes in offering liver and intestinal toxicology insights through its proprietary New Approach Methodologies (NAMs), including its NAMkind™ 3D models. These non-animal testing platforms are used to generate human-relevant safety and toxicology data early in the drug discovery and development process, aiming to provide insights before animal studies or clinical trials.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2020-08-19 English
8-K
Share Issue/Capital Change Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a reverse stock split (1-for-20) approved and executed by the company's board of directors, including the filing of a Certificate of Amendment to the Certificate of Incorporation. It also mentions the effective date and trading adjustments related to the reverse stock split. This type of filing is an announcement of a capital structure change, specifically a stock split, which falls under the category of Share Issue/Capital Change. The document is not a full financial report, earnings release, or management discussion, but a regulatory announcement of a capital change event. Therefore, the appropriate classification is SHA (Share Issue/Capital Change). The document length and detail support a high confidence in this classification.
2020-08-17 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive additional proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It announces a one-for-twenty reverse stock split approved by the board and stockholders, details about the stock split, and information related to the upcoming 2020 Annual Meeting of Stockholders. It also references the definitive proxy statement and annual report filed earlier but does not contain the full proxy statement or annual report itself. The document is primarily solicitation material related to the annual meeting and voting matters, consistent with proxy solicitation materials. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (8826 characters) and content confirm it is not a brief announcement or a full annual report but a proxy-related filing.
2020-08-17 English
10-Q
Interim / Quarterly Report Q1 2021
2020-08-10 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a definitive proxy statement with additional materials related to the Annual Meeting of Organovo Holdings, Inc. It includes information about the meeting date, voting instructions, election of directors, ratification of auditors, and advisory votes on executive compensation. The presence of proxy materials and voting instructions indicates this is a Proxy Solicitation & Information Statement. The document is not an actual annual report or financial statement but rather materials sent to shareholders to provide information and request votes for the meeting, fitting the Proxy Solicitation & Information Statement category.
2020-08-06 English
DEF 14A
Proxy Solicitation & Information Statement
2020-08-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.